200 related articles for article (PubMed ID: 19956474)
1. Altered synthesis of cartilage-specific proteoglycans by mutant human cartilage oligomeric matrix protein.
Kwak YH; Roh JY; Lee KS; Park HW; Kim HW
Clin Orthop Surg; 2009 Dec; 1(4):181-7. PubMed ID: 19956474
[TBL] [Abstract][Full Text] [Related]
2. Chondrocyte cell death and intracellular distribution of COMP and type IX collagen in the pseudoachondroplasia growth plate.
Hecht JT; Makitie O; Hayes E; Haynes R; Susic M; Montufar-Solis D; Duke PJ; Cole WG
J Orthop Res; 2004 Jul; 22(4):759-67. PubMed ID: 15183431
[TBL] [Abstract][Full Text] [Related]
3. Cell-type specific trafficking of expressed mutant COMP in a cell culture model for PSACH.
Chen TL; Stevens JW; Cole WG; Hecht JT; Vertel BM
Matrix Biol; 2004 Nov; 23(7):433-44. PubMed ID: 15579310
[TBL] [Abstract][Full Text] [Related]
4. Secretion of cartilage oligomeric matrix protein is affected by the signal peptide.
Holden P; Keene DR; Lunstrum GP; Bächinger HP; Horton WA
J Biol Chem; 2005 Apr; 280(17):17172-9. PubMed ID: 15749701
[TBL] [Abstract][Full Text] [Related]
5. COMP mutations, chondrocyte function and cartilage matrix.
Hecht JT; Hayes E; Haynes R; Cole WG
Matrix Biol; 2005 Jan; 23(8):525-33. PubMed ID: 15694129
[TBL] [Abstract][Full Text] [Related]
6. Expression of mutant cartilage oligomeric matrix protein in human chondrocytes induces the pseudoachondroplasia phenotype.
Merritt TM; Alcorn JL; Haynes R; Hecht JT
J Orthop Res; 2006 Apr; 24(4):700-7. PubMed ID: 16514635
[TBL] [Abstract][Full Text] [Related]
7. Transgenic mice expressing D469Delta mutated cartilage oligomeric matrix protein (COMP) show growth plate abnormalities and sternal malformations.
Schmitz M; Niehoff A; Miosge N; Smyth N; Paulsson M; Zaucke F
Matrix Biol; 2008 Mar; 27(2):67-85. PubMed ID: 17889519
[TBL] [Abstract][Full Text] [Related]
8. Characterization of cartilage oligomeric matrix protein (COMP) in human normal and pseudoachondroplasia musculoskeletal tissues.
Hecht JT; Deere M; Putnam E; Cole W; Vertel B; Chen H; Lawler J
Matrix Biol; 1998 Aug; 17(4):269-78. PubMed ID: 9749943
[TBL] [Abstract][Full Text] [Related]
9. Cartilage oligomeric matrix protein associates with granulin-epithelin precursor (GEP) and potentiates GEP-stimulated chondrocyte proliferation.
Xu K; Zhang Y; Ilalov K; Carlson CS; Feng JQ; Di Cesare PE; Liu CJ
J Biol Chem; 2007 Apr; 282(15):11347-55. PubMed ID: 17307734
[TBL] [Abstract][Full Text] [Related]
10. Selective intracellular retention of extracellular matrix proteins and chaperones associated with pseudoachondroplasia.
Vranka J; Mokashi A; Keene DR; Tufa S; Corson G; Sussman M; Horton WA; Maddox K; Sakai L; Bächinger HP
Matrix Biol; 2001 Nov; 20(7):439-50. PubMed ID: 11691584
[TBL] [Abstract][Full Text] [Related]
11. Chondrogenic differentiation of induced pluripotent stem cells from osteoarthritic chondrocytes in alginate matrix.
Wei Y; Zeng W; Wan R; Wang J; Zhou Q; Qiu S; Singh SR
Eur Cell Mater; 2012 Jan; 23():1-12. PubMed ID: 22241609
[TBL] [Abstract][Full Text] [Related]
12. Unique matrix structure in the rough endoplasmic reticulum cisternae of pseudoachondroplasia chondrocytes.
Merritt TM; Bick R; Poindexter BJ; Alcorn JL; Hecht JT
Am J Pathol; 2007 Jan; 170(1):293-300. PubMed ID: 17200202
[TBL] [Abstract][Full Text] [Related]
13. Ribozyme-mediated reduction of wild-type and mutant cartilage oligomeric matrix protein (COMP) mRNA and protein.
Alcorn JL; Merritt TM; Farach-Carson MC; Wang HH; Hecht JT
RNA; 2009 Apr; 15(4):686-95. PubMed ID: 19237461
[TBL] [Abstract][Full Text] [Related]
14. The fate of cartilage oligomeric matrix protein is determined by the cell type in the case of a novel mutation in pseudoachondroplasia.
Maddox BK; Keene DR; Sakai LY; Charbonneau NL; Morris NP; Ridgway CC; Boswell BA; Sussman MD; Horton WA; Bächinger HP; Hecht JT
J Biol Chem; 1997 Dec; 272(49):30993-7. PubMed ID: 9388247
[TBL] [Abstract][Full Text] [Related]
15. Combined role of type IX collagen and cartilage oligomeric matrix protein in cartilage matrix assembly: cartilage oligomeric matrix protein counteracts type IX collagen-induced limitation of cartilage collagen fibril growth in mouse chondrocyte cultures.
Blumbach K; Bastiaansen-Jenniskens YM; DeGroot J; Paulsson M; van Osch GJ; Zaucke F
Arthritis Rheum; 2009 Dec; 60(12):3676-85. PubMed ID: 19950300
[TBL] [Abstract][Full Text] [Related]
16. Pseudoachondroplasia is caused through both intra- and extracellular pathogenic pathways.
Dinser R; Zaucke F; Kreppel F; Hultenby K; Kochanek S; Paulsson M; Maurer P
J Clin Invest; 2002 Aug; 110(4):505-13. PubMed ID: 12189245
[TBL] [Abstract][Full Text] [Related]
17. Calreticulin, PDI, Grp94 and BiP chaperone proteins are associated with retained COMP in pseudoachondroplasia chondrocytes.
Hecht JT; Hayes E; Snuggs M; Decker G; Montufar-Solis D; Doege K; Mwalle F; Poole R; Stevens J; Duke PJ
Matrix Biol; 2001 Jul; 20(4):251-62. PubMed ID: 11470401
[TBL] [Abstract][Full Text] [Related]
18. Comparative proteomic analysis of normal and collagen IX null mouse cartilage reveals altered extracellular matrix composition and novel components of the collagen IX interactome.
Brachvogel B; Zaucke F; Dave K; Norris EL; Stermann J; Dayakli M; Koch M; Gorman JJ; Bateman JF; Wilson R
J Biol Chem; 2013 May; 288(19):13481-92. PubMed ID: 23530037
[TBL] [Abstract][Full Text] [Related]
19. Retention of cartilage oligomeric matrix protein (COMP) and cell death in redifferentiated pseudoachondroplasia chondrocytes.
Hecht JT; Montufar-Solis D; Decker G; Lawler J; Daniels K; Duke PJ
Matrix Biol; 1998 Dec; 17(8-9):625-33. PubMed ID: 9923655
[TBL] [Abstract][Full Text] [Related]
20. Disruption of extracellular matrix structure may cause pseudoachondroplasia phenotypes in the absence of impaired cartilage oligomeric matrix protein secretion.
Schmitz M; Becker A; Schmitz A; Weirich C; Paulsson M; Zaucke F; Dinser R
J Biol Chem; 2006 Oct; 281(43):32587-95. PubMed ID: 16928687
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
